Invesco Ltd. Igm Biosciences, Inc. Transaction History

Invesco Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $7,282 - $11,508	822 Added 7.84%	11,312 $104,000
Q1 2023 May 12, 2023	BUY	$13.74 - $25.76 $144,132 - $270,222	10,490 New	10,490 $144,000
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $126,417 - $304,198	-4,582 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $27,487 - $37,891	418 Added 10.04%	4,582 $301,000
Q2 2021 Aug 17, 2021	BUY	$57.98 - $96.6 $241,428 - $402,242	4,164 New	4,164 $346,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.